Trials / Completed
CompletedNCT04322461
Effect of Exercise, Endocannabinoids and Ketones on Cerebral Metabolism in a Cognitive Disorders Population
Effect of Exercise, Endocannabinoids and Ketones on Cerebral Metabolism in a Cognitive Disorders Population : Pilot Project PARKA
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Université de Sherbrooke · Academic / Other
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
A two months intervention in which two groups of cognitive disorders, Parkinson and Alzheimer's disease, will receive 50g/day of a commercial MCT supplement combined with supervised aerobic exercise 3 times/week. Cognition and ketones will be assess before and after the intervention, along with endocannabinoids plasma concentrations.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Betaquik MCT supplement | 50g/day divided in 3. Breakfast, lunch and dinner |
Timeline
- Start date
- 2022-05-01
- Primary completion
- 2024-05-27
- Completion
- 2024-05-27
- First posted
- 2020-03-26
- Last updated
- 2025-06-03
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT04322461. Inclusion in this directory is not an endorsement.